{"id":"https://openalex.org/W4252732887","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps2636","title":"A phase 1 study of a novel inhibitor of protein phosphatase 2A alone and with docetaxel.","display_name":"A phase 1 study of a novel inhibitor of protein phosphatase 2A alone and with docetaxel.","publication_year":2014,"publication_date":"2014-05-20","ids":{"openalex":"https://openalex.org/W4252732887","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps2636"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.15_suppl.tps2636","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps2636","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps2636","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022022603","display_name":"Vincent M. Chung","orcid":"https://orcid.org/0000-0001-9475-808X","observed_orcids":["https://orcid.org/0000-0001-9475-808X"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vincent M. Chung","raw_affiliation_strings":["City of Hope, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope, Duarte, CA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071440718","display_name":"Aaron Scott Mansfield","orcid":"https://orcid.org/0000-0002-9483-6903","observed_orcids":["https://orcid.org/0000-0002-9483-6903"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Scott Mansfield","raw_affiliation_strings":["Department of Medical Oncology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004889714","display_name":"Kovach John","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123376","display_name":"Lixte (United States)","ror":"https://ror.org/030bhtx29","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123376"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Kovach","raw_affiliation_strings":["Lixte Biotechnology Holdings, Inc., East Setauket, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lixte Biotechnology Holdings, Inc., East Setauket, NY","institution_ids":["https://openalex.org/I4210123376"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"15_suppl","first_page":"TPS2636","last_page":"TPS2636"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.5292999744415283,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.5292999744415283,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.20190000534057617,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.04610000178217888,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protein-phosphatase-2a","display_name":"protein phosphatase 2A","score":0.9300000071525574},{"id":"https://openalex.org/keywords/pp2a-inhibition","display_name":"PP2A inhibition","score":0.7459999918937683},{"id":"https://openalex.org/keywords/lb-100","display_name":"LB-100","score":0.9980000257492065},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9010000228881836},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6740000247955322},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9710000157356262},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.5899999737739563},{"id":"https://openalex.org/keywords/parp-inhibitor-sensitivity","display_name":"PARP inhibitor sensitivity","score":0.6320000290870667},{"id":"https://openalex.org/keywords/homologous-recombination-repair","display_name":"homologous recombination repair","score":0.9750000238418579},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.6899999976158142},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.675000011920929},{"id":"https://openalex.org/keywords/cip2a","display_name":"CIP2A","score":0.7350000143051147},{"id":"https://openalex.org/keywords/sets","display_name":"sets","score":0.8489999771118164},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.5559999942779541},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5109999775886536},{"id":"https://openalex.org/keywords/s-phase-cell-cycle","display_name":"S-phase cell cycle","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9187272787094116},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8387925028800964},{"id":"https://openalex.org/C178666793","wikidata":"https://www.wikidata.org/wiki/Q422476","display_name":"Phosphatase","level":3,"score":0.45170700550079346},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43868470191955566},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4198577105998993},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4154800772666931},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3917856216430664},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2995746433734894},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.20442736148834229},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11737418174743652},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.15_suppl.tps2636","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps2636","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps2636","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2527149191","https://openalex.org/W2408189227","https://openalex.org/W1606775748","https://openalex.org/W2561714923","https://openalex.org/W1988047753","https://openalex.org/W4308203166","https://openalex.org/W3183096025","https://openalex.org/W2772173460","https://openalex.org/W2914737396","https://openalex.org/W2122809300"],"abstract_inverted_index":{"TPS2636":[0],"Background:":[1],"Protein":[2],"phosphatase":[3],"2A":[4],"(PP2A)":[5],"is":[6],"a":[7,72,180,243],"target":[8],"of":[9,41,45,68,80,103,113,126,130,177,191,202,232,306,316],"several":[10,62],"viral":[11],"oncoproteins":[12],"suggesting":[13],"that":[14,66,155],"it":[15],"contributes":[16],"to":[17,57,106,147,152,163,171,198,256,266],"tumor":[18],"suppression.":[19],"Several":[20],"human":[21,91],"cancers":[22],"have":[23,64,279,294,301,310,320],"decreased":[24,50],"PP2A":[25,33,51,59,69,104,141,156],"function":[26],"by":[27,30,110],"mutations":[28],"or":[29,275,308],"increased":[31],"cellular":[32],"inhibitors,":[34],"CIP2A":[35],"and":[36,43,87,120,124,133,183,217,261,319,325],"SET,":[37],"including":[38,128],"about":[39],"40%":[40],"NSCLC":[42],"60%":[44],"prostate":[46],"cancers.":[47],"Tumors":[48],"with":[49,71,116,186,222,246,273],"activity":[52,70],"may":[53,158],"be":[54,254,264,291],"particularly":[55],"vulnerable":[56],"further":[58],"inhibition.":[60],"Recently,":[61],"groups":[63],"shown":[65],"inhibition":[67,102,125,149],"novel":[73],"small":[74],"molecule,":[75],"LB-100,":[76],"enhances":[77],"the":[78,153,173,200,218,230],"effectiveness":[79],"anticancer":[81],"agents":[82],"(temozolomide,":[83],"docetaxel,":[84],"doxorubicin,":[85],"cisplatin)":[86],"radiation":[88],"against":[89],"different":[90],"cancer":[92,160],"cell":[93,114,161],"types":[94],"in":[95,140,184],"vivo":[96],"without":[97],"significantly":[98],"enhancing":[99],"toxicity.":[100],"LB-100":[101,178,203,233,251],"appears":[105],"potentiate":[107],"cytotoxic":[108],"therapy":[109],"altering":[111],"regulation":[112],"cycle":[115],"enhanced":[117],"S-phase":[118],"entry":[119],"delayed":[121],"mitotic":[122],"exit":[123],"DNA-damage-response":[127],"suppression":[129],"p53":[131],"induction":[132],"homologous":[134],"recombination":[135],"repair":[136],"(HRR).":[137],"Impaired":[138],"HRR":[139],"deficient":[142],"cells":[143],"increases":[144],"their":[145],"sensitivity":[146],"PARP":[148],"(PARPi),":[150],"leading":[151],"suggestion":[154],"status":[157,305],"indicate":[159],"vulnerability":[162],"PARPi.":[164],"Based":[165],"on":[166,224],"these":[167],"data,":[168],"we":[169],"sought":[170],"determine":[172,199],"maximum":[174],"tolerated":[175],"dose":[176,231],"as":[179,242],"single":[181,244],"agent,":[182],"combination":[185],"docetaxel.":[187],"Methods:":[188],"The":[189],"aims":[190],"this":[192],"two-part":[193],"phase":[194],"I":[195],"study":[196],"are":[197,270],"MTD":[201,219,241],"alone":[204],"given":[205,221,248],"intravenously":[206],"over":[207],"15":[208],"minutes":[209],"daily":[210],"for":[211],"3":[212,215],"days":[213],"every":[214],"weeks,":[216],"when":[220],"docetaxel":[223,247,262,287],"day":[225],"2.":[226],"In":[227,284],"part":[228,285],"2,":[229,286],"will":[234,252,263,290],"start":[235],"two":[236],"levels":[237],"lower":[238],"than":[239],"its":[240,257],"agent":[245],"at":[249],"60mg/m2.":[250],"then":[253],"escalated":[255,265],"MTD,":[258],"if":[259],"tolerated,":[260],"75mg/m2.":[267],"Eligible":[268],"patients":[269,289,299],">=18":[271],"y":[272],"progressive":[274],"metastatic":[276],"tumors":[277],"who":[278,293],"failed":[280,295],"available":[281],"standard":[282,296],"treatment.":[283,297],"na\u00efve":[288],"entered":[292],"All":[298],"must":[300],"an":[302],"ECOG":[303],"performance":[304],"0":[307],"1,":[309],"recovered":[311],"from":[312],"acute":[313],"adverse":[314],"effects":[315],"prior":[317],"therapies,":[318],"adequate":[321],"bone":[322],"marrow,":[323],"renal,":[324],"hepatic":[326],"function.":[327],"Clinical":[328],"trial":[329],"information:":[330],"NCTO1837667.":[331]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2022-05-12T00:00:00"}